Latest Prescription Drugs news
Colchicine No Benefit Over Supportive Care for COVID-19
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Panel Mulls Merck COVID-19 Antiviral Pill
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Merck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
posted November 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Frequent Cannabis Use Linked to Epilepsy Severity Monthly Specialist Briefings
Stay Connected
